In a video published Monday on YouTube, PCORI Chief Science Officer Evelyn Whitlock discussed the importance of comparative effectiveness research. "Comparative effectiveness research is really about taking choices that clinicians and patients face and making it clearer what evidence they can bring […]
ICER: Current Prices of CFTR Modulators for CF Boost Outcomes with Heavy Price Tag
The Institute for Clinical and Economic Review (ICER) on Thursday released an Evidence Report assessing the comparative clinical effectiveness and value of cystic fibrosis transmembrane conductance regulator (CFTR) modulators, including combination therapies tezacaftor/ivacaftor (Symdeko, Vertex […]
ICER Set to Review Biologic Treatments for Asthma
The Institute for Clinical and Economic Review (ICER) on Tuesday announced plans to develop a review assessing the comparative clinical effectiveness and value of biologic therapies for moderate-to-severe asthma. The report is set to be reviewed during a November public meeting of the Midwest […]
GAO Reports on CER, PCORI and HHS Activities
The Government Accountability Office on March 23 released findings involved with its review of the Patient-Centered Outcomes Research Institute (PCORI) and the Department of Health and Human Services' (HHS) use of the Patient-Centered Outcomes Research Trust Fund. The fund was established in 2010 […]
Brief Looks into Value-Based Pricing
A recently-published brief takes a look at value-based pricing and how the U.S. can boost drug competition, both of which are aimed at pulling down drug costs. The brief was authored by Institute for Clinical and Economic Review President Steven Pearson, George Mason University Center for Health […]
Articles in Journal Highlight Efforts to Better CER
Three articles in the Journal of Comparative Effectiveness Research focus on the work and recommendations of a CER-centric conference convened last year by the PhRMA Foundation and the Academy of Managed Care Pharmacy. The articles push for steps that aim to ensure future decisions regarding […]
What Role do Payers Play in the Opioid Crisis?
Listen to Judy Zerzan from the Colorado Department of Health Care Policy & Financing talk on the role of payers in the opioid crisis in this short clip. View here. (Source: PCORI, 1/23/18) […]
ICER Releases Report on Emicizumab for Hemophilia A
The Institute for Clinical and Economic Review recently released a Draft Evidence Report assessing the comparative clinical effectiveness and value of emicizumab. The Draft Evidence Report and Draft Voting Questions are now open to public comment until February 23rd at 5 PM ET. Find out more here. […]
BSBSA Chief Medical Officer: CER ‘Very Critical When You Have Options’
Blue Cross Blue Shield Association Chief Medical Office Trent Haywood discussed comparative effectiveness research and how it could facilitate personalized decisions on health care. "Comparative effectiveness research, to me, is very critical when you have options, and when you're considering the […]
ICER to Assess Erenumab for Migraines, Guselkumab and Tildrakizumab
The Institute for Clinical and Economic Review (ICER) will assess the comparative clinical effectiveness and value of erenumab (Amgen/Novartis) for prevention of migraine headaches. The FDA’s decision on whether to approve erenumab is expected in May of 2018. In addition, ICER will conduct an […]
